---
figid: PMC11594113__ijms-25-11935-g001
figtitle: Insulin-like growth factor 1 signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11594113
filename: ijms-25-11935-g001.jpg
figlink: /pmc/articles/PMC11594113/figure/F1/
number: F1
caption: The insulin-like growth factor 1 signaling pathway. Insulin-like growth factor
  1 (IGF-1) activates both phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated
  protein kinase pathways, resulting in cell proliferation, increased protein synthesis,
  and cell growth. Phosphatidylinositol 3-kinase/Akt activates nuclear factor-κB and
  MDM2 for cell survival and inhibits apoptosis through inhibition of BAD and FKHR.
  Akt—Ak strain transforming; BAD—BCL2-associated agonist of cell death; Erk—extracellular-signal-regulated
  kinase; FKHR—Forkhead transcription factor FOXO1; IGF-I—insulin-like growth factor
  1; IGF-IR—insulin-like growth factor 1 receptor; IGFBP—insulin-like growth factor
  binding protein; IRSs—insulin receptor substrate proteins; MDM2—mouse double minute
  2; MEK—mitogen-activated protein kinase; mTOR—mammalian target of rapamycin; NFκB—nuclear
  factor immunoglobulin κ chain enhancer-B cell; P—phosphate; PI3K—phosphatidylinositol
  3-kinase; PIP2—phosphatidylinositol 3, 4 phosphates; PIP3—phosphatidylinositol 3,
  4, 5 phosphates; Raf—rapidly accelerated fibrosarcoma; Ras—rat sarcoma; SHC—Src
  homology/collagen. Figure created in BioRender.com
papertitle: Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell
  Lines
reftext: Diana Luísa Almeida-Nunes, et al. Int J Mol Sci. 2024 Nov;25(22).
year: '2024'
doi: 10.3390/ijms252211935
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: ovarian cancer | linsitinib | IGF-1 signaling pathway | metformin | cell
  viability | apoptosis
automl_pathway: 0.9603007
figid_alias: PMC11594113__F1
figtype: Figure
redirect_from: /figures/PMC11594113__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11594113__ijms-25-11935-g001.html
  '@type': Dataset
  description: The insulin-like growth factor 1 signaling pathway. Insulin-like growth
    factor 1 (IGF-1) activates both phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated
    protein kinase pathways, resulting in cell proliferation, increased protein synthesis,
    and cell growth. Phosphatidylinositol 3-kinase/Akt activates nuclear factor-κB
    and MDM2 for cell survival and inhibits apoptosis through inhibition of BAD and
    FKHR. Akt—Ak strain transforming; BAD—BCL2-associated agonist of cell death; Erk—extracellular-signal-regulated
    kinase; FKHR—Forkhead transcription factor FOXO1; IGF-I—insulin-like growth factor
    1; IGF-IR—insulin-like growth factor 1 receptor; IGFBP—insulin-like growth factor
    binding protein; IRSs—insulin receptor substrate proteins; MDM2—mouse double minute
    2; MEK—mitogen-activated protein kinase; mTOR—mammalian target of rapamycin; NFκB—nuclear
    factor immunoglobulin κ chain enhancer-B cell; P—phosphate; PI3K—phosphatidylinositol
    3-kinase; PIP2—phosphatidylinositol 3, 4 phosphates; PIP3—phosphatidylinositol
    3, 4, 5 phosphates; Raf—rapidly accelerated fibrosarcoma; Ras—rat sarcoma; SHC—Src
    homology/collagen. Figure created in BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - IGF1
  - IGFBP1
  - IGFBP2
  - IGFBP3
  - IGFBP4
  - IGFBP5
  - IGFBP6
  - IGFBP7
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - MDM2
  - BAD
  - FOXO1
  - Ras
  - MEK
  - Nucleus
---
